Acadian Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,721
Closed -$8.28M 1968
2022
Q3
$8.28M Buy
33,721
+27,504
+442% +$7.43M 0.05% 304
2022
Q2
$1.54M Buy
6,217
+6,110
+5,710% +$1.65M 0.01% 698
2022
Q1
$35K Sell
107
-1,148
-91% -$353K ﹤0.01% 1507
2021
Q4
$448K Sell
1,255
-1,658
-57% -$560K ﹤0.01% 1038
2021
Q3
$947K Buy
2,913
+115
+4% +$39K ﹤0.01% 863
2021
Q2
$874K Buy
2,798
+1,210
+76% +$371K ﹤0.01% 968
2021
Q1
$507K Buy
1,588
+75
+5% +$24K ﹤0.01% 1189
2020
Q4
$491K Buy
1,513
+165
+12% +$45.6K ﹤0.01% 1237
2020
Q3
$373K Buy
1,348
+655
+95% +$189K ﹤0.01% 1230
2020
Q2
$168K Buy
+693
New +$139K ﹤0.01% 1554
2019
Q4
Sell
-2,316
Closed -$410K 2121
2019
Q3
$410K Buy
+2,316
New +$501K ﹤0.01% 1142
2019
Q2
Sell
-1,581
Closed -$451K 2101
2019
Q1
$451K Sell
1,581
-9,826
-86% -$3.27M ﹤0.01% 1119
2018
Q4
$3.71M Buy
11,407
+2,567
+29% +$892K 0.02% 430
2018
Q3
$3.98M Sell
8,840
-46,400
-84% -$18.3M 0.02% 417
2018
Q2
$22.6M Buy
55,240
+55,210
+184,033% +$20M 0.1% 187
2018
Q1
$9K Buy
+30
New +$7.6K ﹤0.01% 1561
2017
Q2
Sell
-56
Closed -$7K 1652
2017
Q1
$7K Sell
56
-16,327
-100% -$1.89M ﹤0.01% 1444
2016
Q4
$1.85M Sell
16,383
-3,673
-18% -$426K 0.01% 608
2016
Q3
$2.58M Buy
20,056
+19,937
+16,754% +$2.39M 0.01% 488
2016
Q2
$13K Buy
119
+106
+815% +$10.5K ﹤0.01% 1188
2016
Q1
$1K Sell
13
-58
-82% -$4.9K ﹤0.01% 1344
2015
Q4
$6K Buy
+71
New +$6.03K ﹤0.01% 1292
2015
Q2
Sell
-287
Closed -$20K 1536
2015
Q1
$20K Buy
+287
New +$15.6K ﹤0.01% 1122

Other funds holding ABMD

Acadian Asset Management's ABMD Position: Q4 2022 in Review

Acadian Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 33,721 shares — an estimated $8.28M sold.

Acadian Asset Management first reported a position in ABMD in Q1 2015 and held it in 23 quarters. The position peaked at $22.6M in Q2 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Acadian Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Acadian Asset Management sold 33,721 Abiomed Inc shares in Q4 2022, an estimated $8.28M.
  • Acadian Asset Management first reported a position in Abiomed Inc in Q1 2015 and held it in 23 quarters.
  • Acadian Asset Management's Abiomed Inc position peaked at $22.6M in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Acadian Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.